These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9218084)

  • 1. The absorption of low-dose methotrexate in patients with inflammatory bowel disease.
    Moshkowitz M; Oren R; Tishler M; Konikoff FM; Graff E; Brill S; Yaron M; Gilat T
    Aliment Pharmacol Ther; 1997 Jun; 11(3):569-73. PubMed ID: 9218084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cyclosporin microemulsion in patients with inflammatory bowel disease.
    Latteri M; Angeloni G; Silveri NG; Manna R; Gasbarrini G; Navarra P
    Clin Pharmacokinet; 2001; 40(6):473-83. PubMed ID: 11475470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methotrexate in ulcerative colitis: failure or promise.
    Herfarth HH; Osterman MT; Isaacs KL; Lewis JD; Sands BE
    Inflamm Bowel Dis; 2010 Aug; 16(8):1421-30. PubMed ID: 20186931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
    Kurnik D; Loebstein R; Fishbein E; Almog S; Halkin H; Bar-Meir S; Chowers Y
    Aliment Pharmacol Ther; 2003 Jul; 18(1):57-63. PubMed ID: 12848626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
    Temtem TA; Vickers M; Whitworth J
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
    Egan LJ; Tremaine WJ; Mays DC; Lipsky JJ; Sandborn WJ
    Inflamm Bowel Dis; 2000 Nov; 6(4):286-9. PubMed ID: 11149561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total abdominal colectomy and ileorectal anastomosis for inflammatory bowel disease.
    Pastore RL; Wolff BG; Hodge D
    Dis Colon Rectum; 1997 Dec; 40(12):1455-64. PubMed ID: 9407985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
    Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M; Tron I; Alexandre JL; Cruchant E; Dabadie A; Chaperon J; Robaszkiewicz M; Bretagne JF
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of methotrexate for maintaining remission in inflammatory bowel disease.
    Fraser AG; Morton D; McGovern D; Travis S; Jewell DP
    Aliment Pharmacol Ther; 2002 Apr; 16(4):693-7. PubMed ID: 11929386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
    Seo JK; Yeon KM; Chi JG
    J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice.
    Saibeni S; Bollani S; Losco A; Michielan A; Sostegni R; Devani M; Lupinacci G; Pirola L; Cucino C; Meucci G; Basilisco G; D'Incà R; Bruno S
    Dig Liver Dis; 2012 Feb; 44(2):123-7. PubMed ID: 22051323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.